Contribution of Maternal Antiretroviral Therapy and Breastfeeding to 24-Month Survival in Human Immunodeficiency Virus-Exposed Uninfected Children: An Individual Pooled Analysis of African and Asian Studies

Clinical Infectious Diseases

Volumn 66, Issue 11, 2018, Pages 1668-1677

  Arikawa, Shino ^a   Rollins, Nigel ^b   Jourdain, Gonzague ^c,d,e   Humphrey, Jean ^f   Kourtis, Athena P ^g,h   Hoffman, Irving ⁱ   Essex, Max ^e   Farley, Tim ^j   Coovadia, Hoosen M ^k   Gray, Glenda ^k,l   Kuhn, Louise ^m   Shapiro, Roger ^e   Leroy, Valériane ⁿ   Bollinger, Robert C ^o   Onyango Makumbi, Carolyne ^p   Lockman, Shahin ^e   Marquez, Carina ^q   Doherty, Tanya ^l   Dabis, François ^a   Mandelbrot, Laurent ^r   Le Coeur, Sophie ^c,d,e,s   Rolland, Matthieu ^a   Joly, Pierre ^a   Newell, Marie Louise ^t   Becquet, Renaud ^a   more..

^a UNIVERSITÉ DE BORDEAUX   (France)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Institut de la Recherche pour le Development   (France)

^d CHIANG MAI UNIVERSITY   (Thailand)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j Sigma 3 Services Sarl Scientific and Statistical Solutions   (Switzerland)

^k UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^l SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^m Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

ⁿ UNIVERSITÉ PAUL SABATIER   (France)

^o JOHNS HOPKINS UNIVERSITY   (United States)

^p MAKERERE UNIVERSITY   (Uganda)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r UNIVERSITÉ PARIS DESCARTES   (France)

^s INSTITUT NATIONAL D'ÉTUDES DÉMOGRAPHIQUES   (France)

^t UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

more..

Author keywords

Africa; Asia; children; HIV exposed uninfected; infants; mortality

Indexed keywords

AFRICA; AFRICAN; ANTIRETROVIRAL THERAPY; ARTICLE; ASIA; ASIAN; BREAST FEEDING; CHILD; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LOW BIRTH WEIGHT; MATERNAL AGE; MATERNAL DEATH; MATERNAL MORTALITY; MORTALITY RISK; NONHUMAN; PREDICTION; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL; VERTICAL TRANSMISSION; WORLD HEALTH ORGANIZATION; ADOLESCENT; ADULT; HUMAN IMMUNODEFICIENCY VIRUS 1; INFANT; MALE; PRESCHOOL CHILD; YOUNG ADULT;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; AFRICA; ANTI-HIV AGENTS; ASIA; BREAST FEEDING; CHILD MORTALITY; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; YOUNG ADULT;

EID: 85047545281     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix1102     Document Type: Article

References (57)

1. UNAIDS. Prevention Gap Report. Geneva: UNAIDS, 2016.
2. UNAIDS. On the Fast-track to an AIDS-Free Generation. Geneva: UNAIDS, 2016.
3. Evans C, Jones CE, Prendergast AJ. HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. Lancet Infect Dis 2016; 16:e92-e107.
4. Marinda E, Humphrey JH, Iliff PJ, et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007; 26:519-26.
5. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, et al. Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr 2006; 41:504-8.
6. Powis KM, Kitch D, Ogwu A, et al. Increased risk of preterm delivery among HIVinfected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. J Infect Dis 2011; 204:506-14.
7. Koyanagi A, Humphrey JH, Moulton LH, et al. Predictive value of weight loss on mortality of HIV-positive mothers in a prolonged breastfeeding setting. AIDS Res Hum Retroviruses 2011; 27:1141-8.
8. Shapiro RL, Lockman S, Kim S, et al. Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana. J Infect Dis 2007; 196:562-9.
9. von Mollendorf C, von Gottberg A, Tempia S, et al. Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged 1 year in South Africa, 2009-2013. Clin Infect Dis 2015;60:1346-56.
10. Henderson RA, Miotti PG, Saavedra JM, et al. Longitudinal growth during the first 2 years of life in children born to HIV-infected mothers in Malawi, Africa. Pediatr AIDS HIV Infect 1996; 7:91-7.
11. Moraleda C, de Deus N, Serna-Bolea C, et al. Impact of HIV exposure on health outcomes in HIV-negative infants born to HIV-positive mothers in sub-Saharan Africa. J Acquir Immune Defic Syndr 2014; 65:182-9.
12. Landes M, van Lettow M, Chan AK, et al. Mortality and health outcomes of HIVexposed and unexposed children in a PMTCT cohort in Malawi. PLoS One 2012; 7:e47337.
13. Patel D, Bland R, Coovadia H, et al. Breastfeeding, HIV status and weights in South African children: a comparison of HIV-exposed and unexposed children. AIDS 2010; 24:437-45.
14. Bailey RC, Kamenga MC, Nsuami MJ, et al. Growth of children according to maternal and child HIV, immunological and disease characteristics: a prospective cohort study in Kinshasa, Democratic Republic of Congo. Int J Epidemiol 1999; 28:532-40.
15. Ndirangu J, Newell ML, Thorne C, Bland R. Treating HIV-infected mothers reduces under 5 years of age mortality rates to levels seen in children of HIVuninfected mothers in rural South Africa. Antivir Ther 2012; 17:81-90.
16. Thorne C IP, Chamla D, Romano S, Luo C, Newell ML. Morbidity and mortality in HIV-exposed uninfected children. Future Virol 2015;10:1077-100.
17. Arikawa S, Rollins N, Newell ML, Becquet R. Mortality risk and associated factors in HIV-exposed, uninfected children. Trop Med Int Health 2016; 21:720-34.
18. Taha TE, Hoover DR, Chen S, et al. Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi. Clin Infect Dis 2011; 53:388-95.
19. Owor M, Mwatha A, Donnell D, et al. Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival. J Acquir Immune Defic Syndr 2013; 64:464-71.
20. Kafulafula G, Hoover DR, Taha TE, et al. Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi. J Acquir Immune Defic Syndr 2010; 53:6-13.
21. Chatterjee A, Bosch RJ, Hunter DJ, Fataki MR, Msamanga GI, Fawzi WW. Maternal disease stage and child undernutrition in relation to mortality among children born to HIV-infected women in Tanzania. J Acquir Immune Defic Syndr 2007; 46:599-606.
22. Heidkamp RA, Stoltzfus RJ, Fitzgerald DW, Pape JW. Growth in late infancy among HIV-exposed children in urban Haiti is associated with participation in a clinic-based infant feeding support intervention. J Nutr 2012; 142:774-80.
23. Sutcliffe CG, Scott S, Mugala N, et al. Survival from 9 months of age among HIVinfected and uninfected Zambian children prior to the availability of antiretroviral therapy. Clin Infect Dis 2008; 47:837-44.
24. Marquez C, Okiring J, Chamie G, et al. Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration. J Trop Pediatr 2014; 60:434-41.
25. Dabis F, Msellati P, Meda N, et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant. Lancet 1999; 353:786-92.
26. Msellati P, Meda N, Leroy V, et al. Safety and acceptability of vaginal disinfection with benzalkonium chloride in HIV infected pregnant women in West Africa: ANRS 049b phase II randomized, double blinded placebo controlled trial. DITRAME Study Group. Sex Transm Infect 1999; 75:420-5.
27. Kourtis AP, Wiener J, Kayira D, et al. Health outcomes of HIV-exposed uninfected African infants. AIDS 2013; 27:749-59.
28. Becquet R, Bequet L, Ekouevi DK, et al. Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Côte d'Ivoire. PLoS Med 2007; 4:e17.
29. Onyango-Makumbi C, Bagenda D, Mwatha A, et al. Early weaning of HIVexposed uninfected infants and risk of serious gastroenteritis: findings from two perinatal HIV prevention trials in Kampala, Uganda. J Acquir Immune Defic Syndr 2010; 53:20-7.
30. Chilongozi D, Wang L, Brown L, et al. Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania. Pediatr Infect Dis J 2008; 27:808-14.
31. Bork KA, Cournil A, Read JS, et al. Morbidity in relation to feeding mode in African HIV-exposed, uninfected infants during the first 6 mo of life: the Kesho Bora study. Am J Clin Nutr 2014; 100:1559-68.
32. Shapiro RL, Kitch D, Ogwu A, et al. HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana. AIDS 2013; 27:1911-20.
33. Venkatesh KK, de Bruyn G, Marinda E, et al. Morbidity and mortality among infants born to HIV-infected women in South Africa: implications for child health in resource-limited settings. J Trop Pediatr 2011; 57:109-19.
34. Natureeba P, Ades V, Luwedde F, et al. Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women. J Infect Dis 2014; 210:1938-45.
35. Chopra M, Doherty T, Goga A, Jackson D, Persson LA. Survival of infants in the context of prevention of mother to child HIV transmission in South Africa. Acta Paediatr 2010; 99:694-8.
36. Kammerer B, Kacanek D, Mayondi GK, Lockman S. Pediatric neurodevelopmental functioning following in utero exposure to triple-NRTI-vs. PI-based ART in a randomized trial, Botswana. Washington, D.C.: AIDS, 2012.
37. Rollins NC, Ndirangu J, Bland RM, Coutsoudis A, Coovadia HM, Newell ML. Exclusive breastfeeding, diarrhoeal morbidity and all-cause mortality in infants of HIV-infected and HIV uninfected mothers: an intervention cohort study in KwaZulu Natal, South Africa. PLoS One 2013; 8:e81307.
38. Kuhn L, Sinkala M, Semrau K, et al. Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIVinfected mothers. Clin Infect Dis 2010; 50:437-44.
39. Cressey TR, Punyawudho B, Urien S, et al. Pharmacokinetics of daily nevirapine in neonates at high risk of HIV acquisition. CROI; 22-25 Feb 2016; Boston, Massachusetts.
40. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004; 351:217-28.
41. Singh HK, Gupte N, Kinikar A, et al. High rates of all-cause and gastroenteritis-related hospitalization morbidity and mortality among HIV-exposed Indian infants. BMC Infect Dis 2011; 11:193.
42. Lallemant M, Le Coeur S, Sirirungsi W, et al. Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand. AIDS 2015; 29:2497-507.
43. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach (2006 revision). Geneva, Switzerland: World Health Organization; 2006.
44. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach (2010 version). Geneva, Switzerland: World Health Organization; 2010.
45. Inter-agency Task Team on Prevention of HIV Infections in Pregnant Women MatI. HIV and infant feeding new evidence and programmatic experience: report of a technical consultation. Geneva: WHO, UNICEF, UNAIDS, UNFPA, 2006.
46. Rückinger S, von Kries R, Toschke AM. An illustration of and programs estimating attributable fractions in large scale surveys considering multiple risk factors. BMC Med Res Methodol 2009; 9:7.
47. Benichou J. A review of adjusted estimators of attributable risk. Stat Methods Med Res 2001;10:195-216.
48. Rondeau V, Marzroui Y, Gonzalez JR. frailtypack: An R Package for the Analysis of Correlated Survival Data with Frailty Models Using Penalized Likelihood Estimation or Parametrical Estimation. 2012. 2012; 47:28.
49. Canty A, Ripley BD. boot: Bootstrap R (S-Plus) Functions. 2017. Available at: http://CRAN.R-project.org/package=boot.
50. Wei R, Msamanga GI, Spiegelman D, et al. Association between low birth weight and infant mortality in children born to human immunodeficiency virus 1-infected mothers in Tanzania. Pediatr Infect Dis J 2004; 23:530-5.
51. Kuhn L, Kasonde P, Sinkala M, et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis 2005; 41:1654-61.
52. Slyker JA, Patterson J, Ambler G, et al. Correlates and outcomes of preterm birth, low birth weight, and small for gestational age in HIV-exposed uninfected infants. BMC Pregnancy Childbirth 2014; 14:7.
53. Chikhungu LC, Newell ML, Rollins N. Under-five mortality according to maternal survival: a systematic review and meta-analysis. Bull World Health Organ 2017; 95:281-7.
54. UNICEF. The state of the world's children 2016: a fair chance for every child. New York: United Nations Children's Fund, 2016.
55. Braddick MR, Kreiss JK, Embree JB, et al. Impact of maternal HIV infection on obstetrical and early neonatal outcome. AIDS 1990; 4:1001-5.
56. Bulterys M, Chao A, Munyemana S, et al. Maternal human immunodeficiency virus 1 infection and intrauterine growth: a prospective cohort study in Butare, Rwanda. Pediatr Infect Dis J 1994; 13:94-100.
57. Thorne C, Patel D, Newell ML. Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 2004; 18:2337-9.